Delivery Order SPE2DB20D3303-SPE2DB25FA1BQ
- Not listed
- This federal contract award, valued at $2,002.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 25, 2025. It is not designated as a set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,490.10, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,003.51 firm fixed-price contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract is not a set-aside and has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a ceiling value of $1,079.91 and a completion date of July 14, 2025. The contract is not set-aside, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.91, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The contract has an...
- This is a $28,167.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,224.46 firm fixed-price contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,276.59, is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The award date is October 28, 2024, and the ultimate completion date is October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,236.31, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a firm fixed price pricing type and a completion date of November 22, 2024. It is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,358.08 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1BQDelivery Order
This is a $2,002.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of July 8, 2025 and is not designated as a set-aside. This award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs and other government agencies through multiple delivery orders across different therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/7/25 |